Clinical Trial: Evaluating Symptom Reduction

The foremost lactose intolerance experts in the country were assembled to assist in the development of Lactagen. Twelve years of research and testing have been invested into Lactagen to demonstrate its safety and effectiveness. Our research and testing includes a clinical study and consumer feedback collected from thousands of past Lactagen users.

Clinical Study

Clinical research has shown that the Lactagen program dramatically reduces symptoms of lactose intolerance.

A sixty-subject clinical trial was conducted by Chris Landon, M.D., at the Ventura County Medical Center in Los Angeles, California. The abstract from the study was published in the FASEB Journal.The results of the study show nearly 80% of subjects on Lactagen reported a dramatic reduction of lactose intolerance symptoms after program completion, compared to the placebo group which reported a much smaller reduction in symptom score.

Click here for the full report

After conducting the clinical study, Dr. Landon had this to say about Lactagen:

Customer Data

We have collected survey data from thousands of individuals who have tried Lactagen in order to evaluate the effectiveness of Lactagen. Survey data has shown that 80% of customers experience a substantial reduction of symptoms after completing the program.

The chart below shows the severity of symptoms for all individuals surveyed before going on the Lactagen program. As you can see, before taking Lactagen, 81% reported having severe symptoms.

The next chart shows the severity of symptoms for all customers surveyed after completing the Lactagen program. Only 13% of individuals still experienced severe symptoms of lactose intolerance.